Cargando…
New Treatment Options for Refractory/Resistant CMV Infection
Despite advances in monitoring and treatment, cytomegalovirus (CMV) infections remain one of the most common complications after solid organ transplantation (SOT). CMV infection may fail to respond to standard first- and second-line antiviral therapies with or without the presence of antiviral resis...
Autores principales: | Walti, Carla Simone, Khanna, Nina, Avery, Robin K., Helanterä, Ilkka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10600348/ https://www.ncbi.nlm.nih.gov/pubmed/37901297 http://dx.doi.org/10.3389/ti.2023.11785 |
Ejemplares similares
-
Association of Procurement Time With Pancreas Transplant Outcomes in Brain-Dead Donors
por: Eerola, Verner, et al.
Publicado: (2023) -
Cytokine and Chemokine Secretome and Risk of CMV Infection Following Discontinuation of Valganciclovir Prophylaxis
por: Fernández-Ruiz, Mario, et al.
Publicado: (2023) -
Pasireotide Versus Octreotide in Preventing Complications After Simultaneous Pancreas-Kidney Transplantation
por: Ahopelto, Kaisa, et al.
Publicado: (2023) -
Timing of Organ Procurement From Brain-Dead Donors Associates With Short- and Long-Term Outcomes After Liver Transplantation
por: Eerola, Verner, et al.
Publicado: (2022) -
Factors Associated With Genotypic Resistance and Outcome Among Solid Organ Transplant Recipients With Refractory Cytomegalovirus Infection
por: Tamzali, Yanis, et al.
Publicado: (2023)